









Markets
/
Stocks
/
nasdaq-antx
/

AN2 Therapeutics Inc

ANTX

3.460USD

-0.200-5.46%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

94.72MMarket Cap

LossP/E TTM



AN2 Therapeutics Inc

3.460

-0.200-5.46%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of AN2 Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

0.70%-5.24M

46.91%-6.38M

47.17%-7.60M

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Net income from continuing operations

-15.79%-8.71M

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-100.17%-15.32M

---11.84M

---11.34M

---10.12M

---7.66M

Other non-cash items

79.37%-117.00K

71.14%-211.00K

66.40%-299.00K

59.40%-443.00K

56.58%-567.00K

-14.22%-731.00K

-102.27%-890.00K

-162.26%-1.09M

-267.89%-1.31M

-184.44%-640.00K

-730.19%-440.00K

-2289.47%-416.00K

---355.00K

---225.00K

---53.00K

--19.00K

Change in working capital

111.49%2.19M

654.06%2.39M

-113.23%-2.84M

30.44%-1.58M

194.53%1.04M

-112.76%-431.00K

-190.05%-1.33M

-209.40%-2.27M

-135.50%-1.10M

297.88%3.38M

322.44%1.48M

366.29%2.08M

--3.09M

--849.00K

---664.00K

--445.00K

-Change in prepaid expenses

-80.49%159.00K

880.43%2.51M

-127.04%-1.80M

-41.84%645.00K

231.24%815.00K

-1633.33%-322.00K

31.93%-795.00K

49.46%1.11M

-159.03%-621.00K

-96.69%21.00K

43.82%-1.17M

231.10%742.00K

--1.05M

--634.00K

---2.08M

---566.00K

-Change in other current assets

----

---720.00K

----

-Change in other current liabilities

351.24%1.22M

-174.48%-534.00K

45.61%348.00K

-21.97%-422.00K

-57.65%-484.00K

-26.31%717.00K

--239.00K

---346.00K

---307.00K

--973.00K

----

Cash from non-recurring investing activities

Cash from operating activities

0.70%-5.24M

46.91%-6.38M

47.17%-7.60M

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Investing cash flow

Net cash flow from investment products

204.27%7.17M

-67.36%6.11M

-64.56%5.83M

-65.03%9.19M

-1738.10%-6.88M

129.97%18.72M

108.96%16.46M

141.48%26.29M

-93.06%420.00K

-2595.81%-62.46M

119.95%7.88M

-22.11%10.89M

--6.05M

---2.32M

---39.49M

--13.98M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

204.27%7.17M

-67.36%6.11M

-64.56%5.83M

-65.03%9.19M

-1738.10%-6.88M

129.97%18.72M

108.96%16.46M

141.48%26.29M

-93.06%420.00K

-2595.81%-62.46M

119.95%7.88M

-22.11%10.89M

--6.05M

---2.32M

---39.49M

--13.98M

Financing cash flow

Cash flow from continuous financing activities

--0.00

108.70%48.00K

--0.00

-81.38%65.00K

100.00%0.00

-99.97%23.00K

-100.00%0.00

75.38%349.00K

---321.00K

660760.00%66.07M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.19M

Net cash flow from common stock issuance/repurchase

--0.00

108.70%48.00K

--0.00

-69.35%38.00K

--0.00

-99.97%23.00K

-100.00%0.00

-37.69%124.00K

--0.00

659770.00%65.97M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.20M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

--0.00

-88.00%27.00K

--0.00

-100.00%0.00

--0.00

--225.00K

--0.00

--99.00K

--0.00

100.00%0.00

--0.00

---11.00K

Net cash flow from other financing activities

--0.00

----

---321.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--0.00

108.70%48.00K

--0.00

-81.38%65.00K

100.00%0.00

-99.97%23.00K

-100.00%0.00

75.38%349.00K

---321.00K

660760.00%66.07M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.19M

Net cash flow

Beginning cash balance

-46.27%18.00M

-31.94%18.22M

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

--28.80M

--40.62M

--82.52M

--12.10M

Current period cash flow changes

115.95%1.94M

-103.22%-217.00K

-185.02%-1.76M

-115.10%-1.37M

28.38%-12.15M

182.17%6.74M

-85.28%2.08M

1873.73%9.05M

-971.95%-16.97M

30.62%-8.20M

133.66%14.10M

-100.72%-510.00K

---1.58M

---11.81M

---41.90M

--70.42M

Ending cash balance

-6.60%19.94M

-46.27%18.00M

-31.94%18.22M

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

--27.22M

--28.80M

--40.62M

--82.52M

Free cash flow

0.70%-5.24M

46.91%-6.38M

47.17%-7.60M

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

